Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador

Background The current EAACI/GA2LEN/EDF/WAO guideline for urticaria provide specific recommendations for the diagnostic workup and treatment of patients with chronic spontaneous urticaria (CsU). This study explored if physicians in Ecuador know these recommendations and implement them in their actua...

Full description

Bibliographic Details
Main Authors: A. Cherrez, M. Maurer, K. Weller, J.C. Calderon, D. Simancas-Racines, I. Cherrez Ojeda
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455119300195
_version_ 1818992980105625600
author A. Cherrez
M. Maurer
K. Weller
J.C. Calderon
D. Simancas-Racines
I. Cherrez Ojeda
author_facet A. Cherrez
M. Maurer
K. Weller
J.C. Calderon
D. Simancas-Racines
I. Cherrez Ojeda
author_sort A. Cherrez
collection DOAJ
description Background The current EAACI/GA2LEN/EDF/WAO guideline for urticaria provide specific recommendations for the diagnostic workup and treatment of patients with chronic spontaneous urticaria (CsU). This study explored if physicians in Ecuador know these recommendations and implement them in their actual clinical practice for CsU.Methods We investigated physicians who treat CsU patients in a cross-sectional study using a standardized questionnaire. Descriptive statistics were employed, adjusted logistic regression was performed to assess the link of guideline knowledge and use of therapy.Results Seven hundred forty surveys were collected and analyzed. The mean age of physicians was 42.3 (±12.5) years. Most of the participants (65.1%) were general physicians (GP), 13.7% were pediatricians, 11.0% internists, 6.8% dermatologists or allergists (D/A). Only 18.8% knew the EAACI/GA2LEN/EDF/WAO guideline. 44.5% of GPs searched for CsU etiology in contrast to 90% of D/A. Most common diagnostic test was total serum IgE (83.5%). Most common first line symptomatic treatment was oral corticoids (46.3%), followed by second generation antihistamines (sgAHs, 36.8%). A/D prescribed more sgAHs (regular doses) (74.1 vs 28.6% of GP) (p < 0.05). Experience with omalizumab was reported only by 3.5%, of physicians, and higher rates among who were familiar with the guideline.Conclusion This study shows that the knowledge of guideline recommendations in physicians who treat urticaria patients in Ecuador is low. The diagnostic workup and treatment of CsU patients are largely not in line with guideline recommendations in real life practice settings. We were able to compare results between German and Ecuadorian physicians and found that Ecuadorian physicians have lower awareness of the current guideline (33 vs 18%). Only one-third of physicians reported using regular doses of sgAHs as the first line treatment. Also, only 12.9% of physicians use sgAHs in higher doses and physicians still use fgAHs, particularly pediatricians (42.9%). Our results suggest that disparities in knowledge between physicians from different countries could influence the management of CsU. Knowledge of the guidelines is linked to better choices of treatments. Awareness of guidelines needs to be promoted for better management of chronic urticaria. Keywords: Chronic urticaria, Guidelines, Latin America, Management, Treatment
first_indexed 2024-12-20T20:34:46Z
format Article
id doaj.art-8f6368246c3c43a9b025a8ba5a8b8ffe
institution Directory Open Access Journal
issn 1939-4551
language English
last_indexed 2024-12-20T20:34:46Z
publishDate 2017-01-01
publisher Elsevier
record_format Article
series World Allergy Organization Journal
spelling doaj.art-8f6368246c3c43a9b025a8ba5a8b8ffe2022-12-21T19:27:15ZengElsevierWorld Allergy Organization Journal1939-45512017-01-01101Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in EcuadorA. Cherrez0M. Maurer1K. Weller2J.C. Calderon3D. Simancas-Racines4I. Cherrez Ojeda5Respiralab Research Group, Respiralab, Guayaquil, Ecuador; School of Medicine, University of Heidelberg, Heidelberg, GermanyDepartment of Dermatology and Allergy, Allergie-Centrum-Charité, Charité – Universitätsmedizin Berlin, Berlin, GermanyDepartment of Dermatology and Allergy, Allergie-Centrum-Charité, Charité – Universitätsmedizin Berlin, Berlin, GermanyRespiralab Research Group, Respiralab, Guayaquil, Ecuador; School of Medicine, Universidad Espiritu Santo, Samborondón, Guayas, EcuadorCentro de Investigación en Salud Pública y Epidemiologia Clínica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad Tecnológica Equinoccial, Quito, EcuadorRespiralab Research Group, Respiralab, Guayaquil, Ecuador; School of Medicine, Universidad Espiritu Santo, Samborondón, Guayas, Ecuador; Correspondence:Background The current EAACI/GA2LEN/EDF/WAO guideline for urticaria provide specific recommendations for the diagnostic workup and treatment of patients with chronic spontaneous urticaria (CsU). This study explored if physicians in Ecuador know these recommendations and implement them in their actual clinical practice for CsU.Methods We investigated physicians who treat CsU patients in a cross-sectional study using a standardized questionnaire. Descriptive statistics were employed, adjusted logistic regression was performed to assess the link of guideline knowledge and use of therapy.Results Seven hundred forty surveys were collected and analyzed. The mean age of physicians was 42.3 (±12.5) years. Most of the participants (65.1%) were general physicians (GP), 13.7% were pediatricians, 11.0% internists, 6.8% dermatologists or allergists (D/A). Only 18.8% knew the EAACI/GA2LEN/EDF/WAO guideline. 44.5% of GPs searched for CsU etiology in contrast to 90% of D/A. Most common diagnostic test was total serum IgE (83.5%). Most common first line symptomatic treatment was oral corticoids (46.3%), followed by second generation antihistamines (sgAHs, 36.8%). A/D prescribed more sgAHs (regular doses) (74.1 vs 28.6% of GP) (p < 0.05). Experience with omalizumab was reported only by 3.5%, of physicians, and higher rates among who were familiar with the guideline.Conclusion This study shows that the knowledge of guideline recommendations in physicians who treat urticaria patients in Ecuador is low. The diagnostic workup and treatment of CsU patients are largely not in line with guideline recommendations in real life practice settings. We were able to compare results between German and Ecuadorian physicians and found that Ecuadorian physicians have lower awareness of the current guideline (33 vs 18%). Only one-third of physicians reported using regular doses of sgAHs as the first line treatment. Also, only 12.9% of physicians use sgAHs in higher doses and physicians still use fgAHs, particularly pediatricians (42.9%). Our results suggest that disparities in knowledge between physicians from different countries could influence the management of CsU. Knowledge of the guidelines is linked to better choices of treatments. Awareness of guidelines needs to be promoted for better management of chronic urticaria. Keywords: Chronic urticaria, Guidelines, Latin America, Management, Treatmenthttp://www.sciencedirect.com/science/article/pii/S1939455119300195
spellingShingle A. Cherrez
M. Maurer
K. Weller
J.C. Calderon
D. Simancas-Racines
I. Cherrez Ojeda
Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador
World Allergy Organization Journal
title Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador
title_full Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador
title_fullStr Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador
title_full_unstemmed Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador
title_short Knowledge and management of chronic spontaneous urticaria in Latin America: a cross-sectional study in Ecuador
title_sort knowledge and management of chronic spontaneous urticaria in latin america a cross sectional study in ecuador
url http://www.sciencedirect.com/science/article/pii/S1939455119300195
work_keys_str_mv AT acherrez knowledgeandmanagementofchronicspontaneousurticariainlatinamericaacrosssectionalstudyinecuador
AT mmaurer knowledgeandmanagementofchronicspontaneousurticariainlatinamericaacrosssectionalstudyinecuador
AT kweller knowledgeandmanagementofchronicspontaneousurticariainlatinamericaacrosssectionalstudyinecuador
AT jccalderon knowledgeandmanagementofchronicspontaneousurticariainlatinamericaacrosssectionalstudyinecuador
AT dsimancasracines knowledgeandmanagementofchronicspontaneousurticariainlatinamericaacrosssectionalstudyinecuador
AT icherrezojeda knowledgeandmanagementofchronicspontaneousurticariainlatinamericaacrosssectionalstudyinecuador